Literature DB >> 20048083

Evaluation, diagnosis, and treatment of gastrointestinal disorders in individuals with ASDs: a consensus report.

Timothy Buie1, Daniel B Campbell, George J Fuchs, Glenn T Furuta, Joseph Levy, Judy Vandewater, Agnes H Whitaker, Dan Atkins, Margaret L Bauman, Arthur L Beaudet, Edward G Carr, Michael D Gershon, Susan L Hyman, Pipop Jirapinyo, Harumi Jyonouchi, Koorosh Kooros, Rafail Kushak, Pat Levitt, Susan E Levy, Jeffery D Lewis, Katherine F Murray, Marvin R Natowicz, Aderbal Sabra, Barry K Wershil, Sharon C Weston, Lonnie Zeltzer, Harland Winter.   

Abstract

Autism spectrum disorders (ASDs) are common and clinically heterogeneous neurodevelopmental disorders. Gastrointestinal disorders and associated symptoms are commonly reported in individuals with ASDs, but key issues such as the prevalence and best treatment of these conditions are incompletely understood. A central difficulty in recognizing and characterizing gastrointestinal dysfunction with ASDs is the communication difficulties experienced by many affected individuals. A multidisciplinary panel reviewed the medical literature with the aim of generating evidence-based recommendations for diagnostic evaluation and management of gastrointestinal problems in this patient population. The panel concluded that evidence-based recommendations are not yet available. The consensus expert opinion of the panel was that individuals with ASDs deserve the same thoroughness and standard of care in the diagnostic workup and treatment of gastrointestinal concerns as should occur for patients without ASDs. Care providers should be aware that problem behavior in patients with ASDs may be the primary or sole symptom of the underlying medical condition, including some gastrointestinal disorders. For these patients, integration of behavioral and medical care may be most beneficial. Priorities for future research are identified to advance our understanding and management of gastrointestinal disorders in persons with ASDs.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20048083     DOI: 10.1542/peds.2009-1878C

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  232 in total

1.  Consensus treatment plans for induction therapy of newly diagnosed proliferative lupus nephritis in juvenile systemic lupus erythematosus.

Authors:  Rina Mina; Emily von Scheven; Stacy P Ardoin; B Anne Eberhard; Marilynn Punaro; Norman Ilowite; Joyce Hsu; Marisa Klein-Gitelman; L Nandini Moorthy; Eyal Muscal; Suhas M Radhakrishna; Linda Wagner-Weiner; Matthew Adams; Peter Blier; Lenore Buckley; Elizabeth Chalom; Gaëlle Chédeville; Andrew Eichenfield; Natalya Fish; Michael Henrickson; Aimee O Hersh; Roger Hollister; Olcay Jones; Lawrence Jung; Deborah Levy; Jorge Lopez-Benitez; Deborah McCurdy; Paivi M Miettunen; Ana I Quintero-del Rio; Deborah Rothman; Ornella Rullo; Natasha Ruth; Laura E Schanberg; Earl Silverman; Nora G Singer; Jennifer Soep; Reema Syed; Larry B Vogler; Ali Yalcindag; Cagri Yildirim-Toruner; Carol A Wallace; Hermine I Brunner
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-03       Impact factor: 4.794

Review 2.  Networking in autism: leveraging genetic, biomarker and model system findings in the search for new treatments.

Authors:  Jeremy Veenstra-VanderWeele; Randy D Blakely
Journal:  Neuropsychopharmacology       Date:  2011-09-21       Impact factor: 7.853

3.  Risperidone-related improvement of irritability in children with autism is not associated with changes in serum of epidermal growth factor and interleukin-13.

Authors:  Zuzana Tobiasova; Klaas H B van der Lingen; Lawrence Scahill; James F Leckman; Yan Zhang; Wookjin Chae; James T McCracken; Christopher J McDougle; Benedetto Vitiello; Elaine Tierney; Michael G Aman; L Eugene Arnold; Liliya Katsovich; Pieter J Hoekstra; Fred Volkmar; Alfred L M Bothwell; Ivana Kawikova
Journal:  J Child Adolesc Psychopharmacol       Date:  2011-11-09       Impact factor: 2.576

Review 4.  Medical comorbidities in autism: challenges to diagnosis and treatment.

Authors:  Margaret L Bauman
Journal:  Neurotherapeutics       Date:  2010-07       Impact factor: 7.620

Review 5.  Host Microbiota Contributes to Health and Response to Disease.

Authors:  Rajeev Aurora; Thomas Sanford
Journal:  Mo Med       Date:  2015 Jul-Aug

6.  The Brain-Gut-Microbiome Axis: What Role Does It Play in Autism Spectrum Disorder?

Authors:  Ruth Ann Luna; Tor C Savidge; Kent C Williams
Journal:  Curr Dev Disord Rep       Date:  2016-02-26

7.  Behavioral Phenotype of ASD Preschoolers with Gastrointestinal Symptoms or Food Selectivity.

Authors:  Margherita Prosperi; Elisa Santocchi; Giulia Balboni; Antonio Narzisi; Margherita Bozza; Francesca Fulceri; Fabio Apicella; Roberta Igliozzi; Angela Cosenza; Raffaella Tancredi; Sara Calderoni; Filippo Muratori
Journal:  J Autism Dev Disord       Date:  2017-11

8.  Bone Mineral Density in Boys Diagnosed with Autism Spectrum Disorder: A Case-Control Study.

Authors:  Kelly Barnhill; Lucas Ramirez; Alan Gutierrez; Wendy Richardson; C Nathan Marti; Amy Potts; Rebeca Shearer; Claire Schutte; Laura Hewitson
Journal:  J Autism Dev Disord       Date:  2017-11

9.  Polymorphisms in Receptors Involved in Opsonic and Nonopsonic Phagocytosis, and Correlation with Risk of Infection in Oncohematology Patients.

Authors:  M Carmen Herrero-Sánchez; Eduardo B Angomás; Cristina de Ramón; Juan J Tellería; Luis A Corchete; Sara Alonso; M Del Carmen Ramos; María J Peñarrubia; Saioa Márquez; Nieves Fernández; Luis J García Frade; Mariano Sánchez Crespo
Journal:  Infect Immun       Date:  2018-11-20       Impact factor: 3.441

Review 10.  Clinical spectrum of food allergies: a comprehensive review.

Authors:  Marco H-K Ho; Wilfred H-S Wong; Christopher Chang
Journal:  Clin Rev Allergy Immunol       Date:  2014-06       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.